Wuppertal, Germany

Michael Schedel


Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 95(Granted Patents)


Location History:

  • Wuppertal-Elberfeld, DE (1992)
  • Wuppertal, DE (1981 - 2000)

Company Filing History:


Years Active: 1981-2000

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Michael Schedel

Introduction

Michael Schedel is a distinguished inventor based in Wuppertal, Germany. With a portfolio comprising six patents, Schedel has made significant contributions to the field of biotechnology, particularly in fermentation processes and medicinal compounds. His innovative spirit and dedication to research have paved the way for advancements that could substantially impact the medical and pharmaceutical industries.

Latest Patents

Among Schedel's latest patents is an osmotically controlled fermentation process aimed at the preparation of acarbose. This invention relates to a novel fermentative process that enhances the yield by monitoring and manipulating the osmolality in the fermentation solution. Furthermore, Schedel has developed recombinant aprotinin variants through a genetically engineered process. These variants include an aprotinin with a deletion of proline at position 2 or an addition of alanine-(-2)-glutamine-(-1), making them valuable as active ingredients in medicaments.

Career Highlights

Michael Schedel is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work revolves around advancing fermentation technologies and contributing to innovative solutions that support healthcare advancements. Through his research and inventions, he has positioned himself as a key contributor to Bayer's mission of improving health through science.

Collaborations

Throughout his career, Schedel has worked closely with notable colleagues, including Gunther Kinast and Jurgen Ebbers. These collaborations have fostered a productive environment for knowledge exchange and have led to the successful development of groundbreaking inventions that address complex challenges in biotechnology and pharmaceuticals.

Conclusion

Michael Schedel stands out as a prominent figure in the realm of innovation within the biotechnology sector. His patents underscore his ability to blend scientific knowledge with practical application, ultimately leading to advancements that hold great promise for the future of medical treatments. Through his continued dedication to research and collaboration, Schedel is poised to make an even greater impact in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…